Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry Developments

Top Articles
:

Estonia

BMI believes that the use of generic drugs in Estonia is set to increase, following the introduction of a decree aimed at promoting the substitution of generics for prescription drugs.... 2010-03-18


Russia

Pharmaceutical prices in Russia and Ukraine have been under intense scrutiny since the latter part of 2008, as a result of negative economic conditions, associated currency devaluations... 2010-03-17


Lithuania

BMI believes Lithuania's pricing and reimbursement environment is becoming increasingly negative for major pharmaceutical companies and patients. A Government of the Republic of Lithuania... 2010-03-16


More ARTICLES

Latvia

Latvian pharmaceutical company Olainfarm has announced plans to open a representative office in Bangkok during 2010, while also expanding into Central Asian markets. BMI considers... 2010-03-15


Slovenia

Slovenian pharmaceutical company Lek, a division of Novartis's generic arm Sandoz, has opened a new US$3.8mn biopharmaceutical production facility to produce biosimilar epoetin alfa.... 2010-03-12


Czech Republic

The presence of countries from BMI's Emerging Europe Region in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 Submission 2010 remains largely equivalent... 2010-03-11


Slovakia

The next update to Slovakia's medicine price list is due in April 2010, with the Ministry of Health aiming to reference 90% of marketed products. This update is expected to bring... 2010-03-10


Slovenia

The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will... 2010-03-09

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries